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Abstract
Background: Health policy and systems research (HPSR) is an international public good with
potential to orient investments and performance at national level. Identifying research trends and
priorities at international level is therefore important. This paper offers a conceptual framework
and defines the HPSR portfolio as a set of research projects under implementation. The research
portfolio is influenced by factors external to the research system as well as internal to it. These last
include the capacity of research institutions, the momentum of research programs, funding
opportunities and the influence of stakeholder priorities and public opinion. These dimensions can
vary in their degree of coordination, leading to a complementary or a fragmented research
portfolio.
Objective: The main objective is to identify the themes currently being pursued in the research
portfolio and agendas within developing countries and to quantify their frequency in an effort to
identify current research topics and their underlying influences.
Methods: HPSR topics being pursued by developing country producer institutions and their
perceived priorities were identified through a survey between 2000 and 2002. The response to a
call for letters of intent issued by the Alliance in 2000 for a broad range of topics was also analyzed.
The institutions that were the universe of this study consisted of the 176 institutional partners of
the Alliance for Health Policy and Systems Research producing research in low and middle income
countries outside Europe. HPSR topics as well as the beneficiaries or issues and the health
problems addressed were content analyzed. Topics were classified into 19 categories and their
frequency analyzed across groups of countries with similar per capita income. Agendas were
identified by analyzing the source of funding and of project initiation for projects under
implementation.
Results: The highest ranking topic at the aggregate level is "Sector analysis", followed by "Disease
burden" and "Management and organization". Categories at the bottom of this ranking are "Equity",
"Policy process", "Economic policy and health" and "Information systems". "Disease burden" is
more often funded than other topics for which there is more demand or perceived priority.
Analysis suggests few although important differences across priorities, demand for funding and
actual project funding. The donors' agenda coincides most with the ranking of research topics
overall.
Ranking across country income groups shows important differences. Topics that gain prominence
in low income countries are "Disease burden" and "Accessibility". In lower middle income countries
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systems", "Equity" and "Policy process" are more prominent. "Program evaluation" is the most
consistently ranked topic across income regions, showing a neutral influence by donors,
governments or researchers.
Conclusions: The framework proposed offers a basis to identify and contrast research needs,
projects and products at the international level and to identify the actor agendas and their influence.
Research gaps are suggested when comparing topic ranking against the challenges to health system
strengthening and scaling up of disease control programs. Differences across per capita income
groups suggests the need for differentiated priority setting mechanisms guiding international
support. Data suggests that stakeholders have different agendas, and that donors predominate in
determining the research portfolio. High-level consensus building at the national and international
levels is necessary to ensure that the diverse agendas play a complementary role in support of
health system objectives.
The Ministerial Summit for Health Research to be held in Mexico in November 2004 should be an 
opportunity to analyze further data and to commit funding for priorities identified through sharing 
and discussion of agendas.
Background
Countries and international agencies have made a quali-
tative leap in the funding of the global disease challenges.
The Global Fund for AIDS, TB and Malaria has received
pledges totalling over US$ 2 billion. Bilateral donors are
also making important funding contributions. In this con-
text, strengthening of health systems has become a critical
issue. Research can play a major role to identify the best
policies to channel massive efforts, to ensure that vertical
approaches do not fragment fragile health systems and to
monitor and evaluate progress. How relevant is the
research effort being undertaken in developing countries,
and how is the agenda being driven?
WHO is organizing the Ministerial Summit on Health
Research, to be held in Mexico City, 23 to 26 November,
2004. The main theme will be the role of health research
in meeting the Millennium Development Goals. Health
policy and systems research (HPSR) will have a promi-
nent role in the context of the scaling up of efforts against
major diseases and child and maternal mortality. Looking
towards the Summit, WHO established a task force to
identify HPSR priorities as an effort to advocate for major
funding in this area. The Alliance for Health Policy and
Systems Research, an initiative of the Global Forum for
Health Research in collaboration with WHO, has been
promoting since its inception in 2000 the identification of
research priorities among producer institutions in devel-
oping countries.
This paper proposes a conceptual framework and a meth-
odology to think about the HPSR research portfolio, the
agendas that influence it and the priority setting process.
The paper makes the case for the formulation of HPSR pri-
orities at national, international and global levels. A pre-
vious article [1] looked at research capacity among
Alliance partner institutions in the South and identified
the need to increase funding to establish long term
research projects as a basis for sustainable capacity build-
ing. Using data from the same survey, indicators are pro-
posed to assess the priority setting process on the basis of
various types of data. The scope and value of the concep-
tual framework and its indicators are illustrated by pre-
senting the HPSR topic ranking on the basis of Alliance
partner contributions and the influence upon it of country
income and actor agendas. A forthcoming paper will
present findings from a new survey now being completed
and covering the universe of research producers in the
South.
Conceptual framework
Priority setting efforts are often bogged down because of
inadequate methods of categorization of the research that
is undertaken and the influences shaping it. These influ-
ences, in turn, are often not adequately understood,
including the nature and role of priorities. The conceptual
framework proposed here strives to offer some simple def-
initions of the research portfolio and its various influ-
ences, as well as indicators to measure and relate these
concepts.
The nature of overall health research has been defined in
terms of basic, applied and strategic research. These cate-
gories are useful to guide investment decisions which
might maximize benefit [2,3]. However, within the field
of health policy and systems research, little effort has been
given to the classification of what is studied. Before prior-
ities can be identified, it is important to be able to agree
on what is studied through an analysis of the dimensions
that characterize the object of research. Furthermore, it isPage 2 of 12
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of the research and the factors shaping this choice at vari-
ous levels.
The HPSR portfolio
To identify the object of research the concept of the
research portfolio can be useful. The HPSR portfolio can
be defined as the current set of research projects on health
system structures, functions, processes and results at
national, international and global levels. Projects, as dis-
tinct from plans or priorities, would include the commit-
ment of resources towards a specific, time-bound aim and
a set of objectives.
It has been proposed that the research portfolio should be
analyzed along three dimensions of strategic importance:
where to make investments, that is, the identification of
the object of research or thematic areas in which invest-
ments are made; the type of investment research and
development (R & D) instrument used and the resources
spent through each area and type of instrument [3]. While
our contribution aims to develop the first dimension, it is
useful to expand on the other two to understand their
interrelations.
The Ad Hoc Committee on Health Research proposed
three types of R & D instruments: discovery oriented
research to develop new health products and interven-
tions; innovation research to adapt efficacious but unaf-
fordable interventions to make them cost-effective, and
implementation R & D to achieve greater efficiency in the
use of existing interventions [2]. Harrison has argued for
the need to consider a fourth instrument of equity R & D
to ensure that the research portfolio responds to the poor
and the underlying health problems in developing
countries.
With regard to funding, there is a need not only to con-
sider investments, but also funding sources and mecha-
nisms. Four broad types of sources can be recognized:
bilateral and multilateral donors, government commis-
sioning, private commissioning, and funding through
resources available to research institutions as part of their
budgets. Each will have different implications for the kind
of knowledge produced and for its possible influence on
the health system [1]. This subject has been explored for
Alliance partners in developing countries, identifying the
amounts and sources of funding for their research portfo-
lio [4].
The object of research
Previous analyses have revealed a complex heterogeneity
along which researchers classify HPSR in developing
countries, which is not surprising in an interdisciplinary
field [5]. However, five overarching dimensions can be
recognized:
• concepts reflecting the health system, such as policy and
financial structures, regulatory functions, processes such
as technology evaluation and quality monitoring, and
results such as satisfaction and health gain
• the levels of the health system, such as the households
and the community, first level facilities and hospitals
• the issues or problems pertaining to the health system
such as priorities, equity and the public private mix
• the populations addressed by the system, such as chil-
dren, mothers and the elderly, or rural and urban
populations
• the health needs addressed, whether in terms of risks or
disease.
While these dimensions can be useful to characterize the
research portfolio, it is clear that there will be overlaps; for
example, equity is both an issue and an attribute of the
health system, particularly if it has been integrated in
monitoring and regulation. In order to make use of these
dimensions it is proposed to consider as the project topic
the first dimension of concepts pertaining to the health
system structures, functions, processes and results. The
topic could then be classified following normative or the-
oretical frameworks or by using the categories researchers
apply in their own research. The other four dimensions
can be used to qualify the research topic as to provide a
more detailed description. These four dimensions could
be selectively used or aggregated to facilitate description
according to the needs at hand.
Analysis of portfolio characteristics
Each of the five project dimensions can be analyzed in
terms of the range of items considered. The ranking and
emphasis of each item can also be revealed by analyzing
its frequency. A research portfolio at any level can be very
focused and comprise a narrow set of topics. Or it can be
wide-ranging across many health system functions, struc-
tures, processes and results. It has been argued that
research portfolios should be more focused on improving
immediate health problems through operations research
in low income countries, where funding and human
resources are very limited [3]. However, the challenges of
scaling up disease control programs call for research at the
health systems level also.
The level of the research portfolio
The level at which the portfolio is analyzed is important,
as it will have different characteristics and uses. AtPage 3 of 12
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projects addressing health and health system problems
within the confines of national borders and governmental
authority as well as sector-wide and inter-sectoral issues.
Examples would be the impact on equity of decentraliza-
tion policies, or the roles played by conflicting policy
actors in scaling up of services. The international research
portfolio would be topic areas which are common across
a number of countries or regions. Identification of the
international portfolio could serve, among other pur-
poses, to fund research at regional or international levels,
to strengthen the critical mass of research available to
inform country policy making and lesson learning across
countries, and to extend the range of methodological
approaches through comparative research [6]. The HPSR
portfolio at global level refers to research themes and
projects that are, by their very nature, supra-national. This
would involve, for example, international financing of
immunization efforts, intellectual property rights in
health research, and development of international disease
control measures.
The HPSR agendas
The HPSR portfolio at any level is influenced by factors
within and outside the research system [7]. Within the
research system the following factors can be identified:
research capacity; research trends and preferences
expressed by researchers and research institutions;
research funding and market opportunities; and research
preferences voiced by policy makers, service managers and
public opinion. Outside the health system the broad fac-
tors shaping the portfolio are the health conditions and
health system problems as well as the cultural, economic
and political context. As a whole, these factors shape
actor-specific research agendas that express ethical, profes-
sional and political values and that influence the alloca-
tion of scarce resources towards alternative project
portfolios.
It is clear that if actor agendas have few areas in common
there will be no consensus and therefore no overall prior-
ities. Significant overlap of interest, on the other hand, can
lead to the identification and formulation of shared
research priorities. Research priorities are therefore
defined as the explicit areas of agreement on, and ranking
of, the object of research across diverse actor agendas. Pri-
orities can then become policy instruments to coordinate
diverse agendas towards a common end without forcing a
single research agenda.
The characteristics of agendas and of priorities can be
identified through the same kinds of dimensions and
indicators as the research portfolio. That is, preferences
can be classified in terms of topics, issues or beneficiaries,
and health problems. The characteristics of the HPSR
agendas and priorities can also be studied in terms of the
range of topics, issues, levels, populations and health
problems. They can also be ranked and their emphasis
revealed by frequency analysis. In this way, the agendas
can be compared across themselves, priorities can be iden-
tified as common topics and issues and with similar rank-
ing and emphasis, and the influence of agendas and
priorities on the actual research portfolio can be assessed.
Priority setting through agenda co-ordination
It has been argued that co-ordination of the various influ-
ences shaping the HPSR portfolio can increase the impact
of research on equity and can contribute to its strategic
role for development [8]. Co-ordination would involve
developing a consensus of researcher, policy maker and
investor agendas. Such a consensus should ideally result
in a highly coherent set of topics across the various actors'
research agendas and, eventually, a high degree of corre-
spondence between agendas and the research portfolio.
HPSR portfolio change through co-ordination would
involve a gradual process of adjustment to new priorities,
project completions, maturation of research capacity and
funding opportunities. Coordination requires interfaces
and mechanisms such as Research Forums and Essential
National Health Research Mechanisms [9] to develop a
consensus while allowing, and even encouraging, critical
differences.
In sum, the HPSR portfolio can encompass a differing
range of topics with diverse rankings and emphases; can
be more or less coherent with respect to researcher, fund-
ing and policy maker agendas; and can be more or less co-
ordinated along a set of shared priorities. The interplay of
these dimensions can give rise to a number of scenarios,
of which three are here illustrated.
a) Co-ordination could lead to focusing the HPSR portfo-
lio on a few, highly cost-effective topics in a situation of
few resources and well identified, high priority needs.
There would be, eventually, a high degree of coherence
across the portfolio and agendas held by various actors.
The risks here would be lack of diversity to foster innova-
tion and healthy criticism.
b) In a situation of plentiful resources the research portfo-
lio and its driving agendas could be wide-ranging and
have little overlap. Specific portfolio segments would cor-
respond with particular agendas, thus satisfying multiple
interests. However, co-ordination through overarching
mechanisms could ensure integration of knowledge
around high level priorities. In this manner a unified,
although highly diverse, HPSR field of enquiry would be
obtained.Page 4 of 12
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low resources, the portfolio could focus on a reduced set
of topics, each satisfying a particular agenda and thus frag-
menting resources and hindering support to health sys-
tem development. If resources are more plentiful, lack of
coordination could lead to a rich but highly dispersed and
inefficient research portfolio with little impact on
development.
Irrespective of the availability of resources, co-ordinating
mechanisms are likely to be important to ensure an effi-
cient use of research resources.
Methodology and Indicators
Two sources of information were used to illustrate the
conceptual framework proposed. The first was a survey of
Alliance-HPSR partner institutions in developing coun-
tries detailing research priorities and project information.
Researchers reported here on the priorities they had
received from policy makers in the course of diverse con-
sultations in the past year. The second source was a data-
base of letters of intent (LOI) submitted to the Alliance for
funding, where projects were justified on the basis of pri-
orities negotiated by researchers and policy makers or
service managers.
Content analysis
This proceeded in several steps. A preliminary list with 24
research topics was identified through an inductive analy-
sis using the research statements expressed in the LOI,
which were the most detailed. This list was then used to
classify research topics in the projects and priorities
expressed in the Alliance partners' profiles. Beneficiaries/
issues and diseases/health problems addressed by the
LOI, projects and priorities were also categorized and clas-
sified at this stage. While projects may have contained
more than one topic or beneficiary/issue, the most prom-
inent one was selected. In a few cases where several topics
were considered this was indicative of a sector-wide anal-
ysis and classified accordingly.
The beneficiaries/issues of the research were classified to
include any of four alternative dimensions: a) the demo-
graphic group: elderly or children/adolescents, b) level of
care: community, primary or hospital, c) the geographical
focus: urban or rural, and d): gender, equity/poverty,
indigenous populations, and public-private mix. When-
ever more than one dimension or aspect was applicable
(which occurred only in a small number of statements), a
decision was made to include the most prominent.
The concept "equity" was classified both as a topic and as
an issue. It was assigned as a topic whenever equity was
the main objective of the research and it was addressed
through a number of health system attributes such as
financing, access, and service delivery. Equity/poverty was
considered as an issue when the poor were identified as
the main subjects of research or when the equity implica-
tions of research directed mainly to another topic were
highlighted as a major concern.
The distribution of statements was analyzed according to
country income group: low income, lower middle income
and upper middle income. These income groups correlate
highly with geographical regions, with LI being mostly in
Africa and Asia, LMI mostly in Asia and with a particular
weight by China, and UMI in Latin America and the Car-
ibbean (table 1).
Two researchers classified all statements independently
and disagreements were discussed and resolved. The 24
topic categories were reduced to 19 to avoid groups with
less than 2% of the total number of statements while
maintaining topic coherence. Table 1 presents the glossary
of terms included under each topic.
The frequency of responses by country for all types of
statements is generally proportional to country popula-
tion, with China, India, Brazil and Bangladesh at the top
of the frequency. However, countries with a strong health
systems research presence are over-represented, such as
Colombia, Argentina, Philippines, Thailand, South Africa,
Uganda, Ghana, Cuba, Costa Rica, Benin, Jamaica and
Tanzania.
Identification of agendas
The range and emphases of the HPSR portfolio and agen-
das were mapped through topic content and frequency
analysis (Figure 1). Project and agenda data were also
aggregated from the two sources to obtain a general map-
ping of topics. This was used to assess coherence across
actor agendas and with the portfolio and to increase the
number of observations to enable analysis by income
level.
Two methods were used to assess the coherence between
the HPSR portfolio and the agendas held by researchers,
policy makers and international donors and partners. The
first method used the survey data to infer the agendas by
observing the topic frequency of: projects proposed and
funded by researchers without external assistance; projects
initiated and funded exclusively by government, and
projects initiated and funded exclusively by international
stakeholders or research partners.
The second method compared the research portfolio
against the agenda expressed by policy makers. The policy
maker agenda was observed through the survey as
reported by researchers and through the LOI as negotiated
with researchers. A negligible influence by the donor, inPage 5 of 12
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given that the call requested priorities within the generic
definition of HPSR presented above.
Each of the three modes of identification of agendas could
have method-specific biases. In the first method, prefer-
ences are derived from the portfolio itself, that is, from
research projects in implementation. Furthermore, the
method isolates the preferences expressed by each actor.
As such, this method could be deemed to reveal most
objectively preferences behind each actor funding or initi-
ating a project. However, projects under implementation
may hide topic preferences that are not translated into
projects or topics that were generated and funded through
joint actor participation.
The observation of negotiated priorities expressed in LOI
captures the mix or balance of researcher-side influences
and policy maker needs. It will therefore reflect a consen-
sus position across each actor. However, it will exclude the
influence of funding opportunities, will not reveal actor-
Table 1: Glossary of Health Policy and Systems Terms Used for Content Analysis
TOPIC TERMS FOUND IN RESPONSES
Accessibility Health seeking behaviour, determinants of utilization, coverage, outreach, referral, barriers to care, willingness and 
capacity to pay, cost-sharing, price regulation, prices, equity in access, demand for health services.
Community participation Community-based strategies, community participation in governance, empowerment, school health, family health 
strategies, social support networks.
Costing & cost 
effectiveness
Determination & evaluation of costs, cost-benefit of services, economic evaluation, cost-effectiveness of resource 
allocation, alternative uses for resources.
Decentralisation/local 
health systems
Decentralization policy and process, impact of decentralization on services and health outcomes, district health system 
development, healthy cities, municipal health services, local government, devolution, community participation in local 
health services.
Disease burden Prevalence and incidence of diseases, mortality and morbidity, disease profiles, health status, health needs, burden of 
disease studies, risk factors, determinants of health and disease other than economic or social policy.
Economic policy and 
health
Free trade agreements and health, TRIPPS and health, economic crises and health, impact of poverty reduction and 
adjustment policies on health, debt reduction and health, social policy and health, social assistance and health issues, 
intersectoral co-ordination, labour policies and health.
Equity Equity of health system, impact of health reforms on equity, equity and poverty, poverty targeting of services, poverty 
and health, exclusion.
Financing Financial mobilization, financial allocation, financing policies, national & district health accounts, financial equity, 
community health financing, financing of specific programmes.
Human resources Personnel management, deployment, migration, motivation, knowledge, attitudes and practices of health personnel, 
satisfaction, quality of life, human resource policy, human resource performance, traditional healers, training and 




Information and communication for the general public, health education strategies and impacts, knowledge attitudes and 
practices (KAP).
Information systems Information needs, informatics, surveillance mechanisms and systems, strengthening of information systems, health 
monitoring systems, establishment of public domain databases, development of indicators for service management and 
policy.
Insurance Risks and benefits covered by insurance schemes, community based health insurance, options for health insurance, 
insurance reform, impact of insurance on health and service outcomes.
Management & 
organization
Health service provider performance, delivery of services, administration, service management strengthening, 
contracting and provider payment mechanisms, impact of privatization on services, performance agreements, impact of 
hospital autonomy on service delivery, stakeholders in service management, community participation in management.
Pharmaceutical policy & 
management
Rational drug use, procurement, logistics, herbal medicine, dispensing practices, pharmaceutical regulation, national drug 
policy, essential lists.
Policy process Stakeholder analysis, role and relationships of actors in the formulation and implementation of policy, role of 
government agencies in policy formulation, role of community and NGOs in policy formulation, factors influencing 
policy process, perceptions of policy, decision-making processes, policy negotiation.
Programme evaluation Evaluation and assessment of impact of policies or programmes on specific diseases or services.
Quality Clinical practice guidelines, evidence-based medicine, quality assurance, patient satisfaction.
Research to evidence Health systems research training, health systems research training, outcomes of research, research impact, policy 
utilization and impact of research, research methods, creation of national HPSR database, priority setting of health 
research, research ethics, essential national health research, dissemination of research.
Sector Analysis Health sector reforms and implications, health systems development, private health service development, intersectoral 
collaboration and co-ordination, public/private mix health care, health care organization, regulation, policy formulation 
on specific diseases, on programmes or on aspects of the health system, sector-wide and system-wide performance.Page 6 of 12
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placed on the LOI (see below).
Priorities based on consultations between researchers and
policy makers and expressed by researchers through a sur-
vey will reveal the understanding and conceptual frame-
work of researchers and may underplay policy-maker
needs. Furthermore, these priorities will be influenced by
the research projects under execution and reported in the
same instrument.
Assessment of coordination between portfolio and agendas
The analysis of relationships or influences across the port-
folio and each of the actor agendas, as well as of similari-
ties or differences between agendas, was undertaken by
correlating topic frequencies across lists and by undertak-
ing a qualitative analysis of changes in rank order and
emphasis.
Analysis of the range and rank of topics across groups of
countries by income was undertaken by aggregating
project and priority topic data into a reference list repre-
senting the combined set of influences on the agenda-set-
ting process, including the portfolio itself. The
aggregation of data into a reference list was mainly a strat-
egy to increase the observations and make the analysis
more reliable, although it may have validity if it describes
the overview of the agenda-setting factors at play. That is,
the actual portfolio can be conceived as a force shaping
the agendas, together with other factors.
Survey and LOI database
The survey of HPSR producer institutions in developing
countries was described in detail elsewhere [1] and
includes information for 108 of the 176 Alliance-HPSR
partners (61% response rate) who produced research in
low and middle income countries outside Europe
between 2000 and 2001. The database contains informa-
tion on the current research portfolio (294 projects were








Priorities negotiated by researchers and
policy makers and expressed in LOI
Priorities derived from researcher-policy maker








project initiation and fundingPage 7 of 12
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stated, with a maximum of 5 per survey). Information on
project initiation and source of funding is available for
270 projects. A total of 39 developing countries out of a
total of 133 were contacted. Respondents are close to one
sixth of the close to 650 institutions known to the Alliance
to be producing HPSR in developing countries.
Biases in the partner database could have occurred as a
result of preferences by certain type of institutions in join-
ing the Alliance HPSR and in answering the questionnaire
required from partners. Over-representation at both levels
could have occurred of more competitive and productive
institutions with larger project portfolios and funding,
and more interest in international funding. On the other
hand, larger institutions may have been discouraged from
responding given the larger number of projects to be
reported, although they would also have more capacity to
respond. Furthermore, the response rate could have been
lower among institutions where producing HPSR is not a
main function.
The LOI database has 403 submissions for research fund-
ing in response to a call by the Alliance-HPSR in 2000.
Applicants requested funding for one year projects in high
priority areas identified jointly by them and national pol-
icy makers and stakeholders. A limitation of this database
is the exclusion of funding requests for projects over one
year as well as topics that would be formulated solely by
researchers. Analysis of the partners' database indicates
that 24% of projects are of longer duration and that up to
34% of projects undertaken are initiated by the research
institution without stakeholder collaboration.
Expansion and standardization
The frequencies of statements for each income region
were expanded proportional to population to make com-
parisons across regions possible. The frequency of state-
ments across the three types of statements (projects, LOI
and priorities) was standardized to give each equal weight
when aggregating them to analyze the combined repre-
sentation of the research portfolio and the agenda-setting
process as a whole.
Responses show a distribution across income regions pro-
portional to population in some cases and with signifi-
cant biases in others (table 2). The low income region (LI)
has 50% of the population and 47% of statements, while
the upper middle income (UMI) region has only 12% of
the population but twice the number of statements, with
22%. The lower middle income (LMI) region is also some-
what under-represented, with 38% of the population and
31% of statements.
The frequency of statements on priorities is as would be
expected for the population in each region. However,
project statements and demand for funding are biased in
favour of UMI, with 25% and 27% of the statements,
respectively, against 12% of population share.
Ranking
This was done for each topic or category within the topic
by rounding percentage differences to integers and
grouping in the same rank all categories falling within the
same percentage.
Table 2: Distribution of Statements According to Type, Content Category and Geographical Region by Income Group
LI LMI UMI TOTAL %
Types of statements Total % Total % Total %
Priorities 198 49 143 36 61 15 402 100
Letters of intent 193 48 101 25 109 27 403 100
Projects 124 42 97 33 73 25 294 100
TOTAL 515 47 341 31 243 22 1099 100
Content categories
Topics 482 46 330 31 237 23 1049 100
Beneficiaries or Issues 217 53 113 28 80 20 410 100
Health Problems 132 58 48 21 48 21 228 100
Total statements by geographical region
Africa 247 77 15 5 57 18 319 100
Asia 260 53 214 44 13 3 487 100
Latin America and the Caribbean 8 3 112 38 173 59 293 100
TOTAL 515 47 341 31 243 22 1099 100
Total population in Geographical 
region
50 38 12 100Page 8 of 12
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This article does not attempt to provide an exhaustive
analysis given the fact that data is limited to Alliance part-
ner producer institutions in the South. The purpose here
is to illustrate the potential of the proposed methodology
and to present the most robust findings. HPSR topics are
first presented and analyzed aggregating in a single list the
topics in the research portfolio as well as in the policy
maker and researcher agendas. This aggregate representa-
tion is then analyzed by groups of countries according to
their per capita income. The influence exerted on the
HPSR portfolio by various actors is then analyzed.
Characteristics of HPSR producers in developing countries
HPSR producer institutions are generally small with an
average of 3 projects, 8 researchers and a project portfolio
worth $155,226 [1]. Only 19% of researchers have a PhD
qualification, although researchers in key disciplines are
well represented and better qualified. Research capacity
and funding are similar across income regions, although
inequalities are apparent.
Overview of topics
A total of 19 research topics were identified when aggregat-
ing portfolio (project) and priority (voiced preferences)
data into the reference list. Topics ranged in frequency from
2% to 11% and were ranked in 8 classes (Table 3). The
highest ranking topic is "Sector analysis" with 11% fol-
lowed by "Disease burden" with 9% and "Management
and organization" with 8%. From here three topics rank
lower equally at 7%, two rank at 6%, seven rank at 4% and
then two each at 3% and 2%. Categories at the bottom of
this ranking are "Equity", "Policy process", "Economic pol-
icy and health" and "Information systems". The emphasis
of topics at the top end is then about five times as greater as
those at the bottom end of the range.
The fact that "Equity" appears so low in the aggregated
ranking could be partly attributable to the fact that this
topic was defined to include only projects and priorities
having equity as the central topic and measuring it
through multi-dimensional approaches such as health
conditions, access to services and financing. A subsidiary
analysis was thus undertaken to include under "Equity"
those projects or priorities addressing equity or poverty as
a secondary, qualifying, role of research on other topics.
This broadened topic "Equity" climbs to fourth rank, at
the same level as "Accessibility", "Program evaluation"
and "Research to policy".
Public and private institutions show no significant
changes in topic ranking (corr = 0.70). "Community par-
ticipation" and "Accessibility" are the only topics with
major differences, ranking higher among private
institutions.
Topic analysis by beneficiary/issue
Out of the total topics classified in the reference list, only
38% (404) were sufficiently focused or detailed to be able
to attribute a beneficiary or specific issue (Table 4). This
was mainly the case with priority statements, which by
their very nature were generic. The beneficiary or issue
statements were spread across the 11 categories identified
through content analysis. The category with least state-
ments had only 2% of the total, and that with most 13%.
Table 3: Ranking of Topic at the Aggregate Level
Rank Topic %
1 Sector Analysis 11
2 Disease burden 9
3 Management & organization 8
4 Accessibility 7
Programme evaluation 7
Research to evidence 7
5 Financing 6
Human resources 6
6 Community participation 4
Costing & cost effectiveness 4
Decentralisation/local health systems 4
Information, Education and Communication 4
Insurance 4














6 Public private mix 6
7 Urban areas 5
8 Elderly 4
9 Indigenous peoples/traditional medicine 3
Rank Health Problem %








4 Other infectious 6
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were "Costing and cost effectiveness", "Policy process"
and "Research to Evidence", with 79% to 96% in this sit-
uation. By contrast, "Community participation" and
"Management & Organization" were the topics least fre-
quently unidentified with beneficiary/issue, at between
30% and 41%.
The most frequent beneficiary/issues were Community,
Equity/poverty Hospital, Gender Primary care and Rural
areas. The three beneficiary/issues least identified were
Urban areas, elderly and Indigenous peoples/traditional
medicine.
The analysis of the correlation between beneficiary/issue
and topic is tentative at this stage given the low frequency
in many of the cells of the 19 by 11 matrix. Two benefici-
aries/issues account for a large part of the focus of research
topics: Community and Hospital as a focus on levels of
care. At the community level the topics of community par-
ticipation, financing, health insurance, decentralization,
policy process, information systems and human resources
are all prominent. At the hospital level the topics of cost-
ing and cost effectiveness, pharmaceutical policy, quality
of care and management and organization are most
prominent. By contrast, the topic of program evaluation is
fairly widely spread across several issues or beneficiaries.
The following topics show also a fairly discreet relation-
ship to beneficiaries/issues: Research on accessibility is
mostly focused on rural areas. Research on disease burden
is prominent among the elderly and children. Economic
policy and health focuses on children. Gender is also an
important component of these three topics. Equity is
focused on indigenous populations. The topic of informa-
tion, education and communication is prominent among
children. Sector analysis focuses mainly on the public pri-
vate mix.
Topic analysis by income level
The differences in ranking of the topics in the reference list
across income regions are shown in the first three col-
umns of Table 5. Larger differences occur in 9 topics,
mostly in lower middle income and upper middle income
countries. This suggests that the reference list reflects more
closely lower income country needs. Largest differences
Table 4: Beneficiaries/Issues According to Topic
Beneficiaries or Issues








A B A B A B A B A B A B A B A B A B A B A B n = B
Accessibility 2 3 10 7 7 7 10 8 7 12 19 20 17 14 19 17 2 11 7 7 42 10
Community participation 9 20 4 3 43 19 13 7 13 12 4 3 13 7 23 6
costing & cost effectiveness 13 3 13 2 38 6 13 4 13 3 13 2 8 2
Decentralisation/local health 
systems
13 5 27 7 7 2 13 8 27 10 7 2 7 2 15 4
Disease burden 15 50 21 19 3 2 3 2 6 4 12 15 9 8 6 4 24 17 3 11 34 8
Economic policy and health 14 10 43 8 14 2 29 4 7 2
Equity 6 10 6 2 78 28 11 22 18 4
Financing 39 17 4 4 9 5 39 18 4 2 4 2 23 6
Human resources 29 9 35 15 6 2 6 4 18 8 6 11 17 4
Inform. Educ. & 
Communication
21 8 7 2 7 2 14 8 14 5 36 11 14 3
Information systems 25 4 38 7 13 2 13 3 13 2 8 2
Insurance 44 13 13 8 19 8 13 4 6 11 6 2 16 4
Management & Organization 2 3 9 7 9 10 49 48 2 4 11 13 2 2 4 4 13 14 47 12
Pharmaceutical policy & 
Mgmnt.
17 5 33 8 8 3 25 6 8 2 8 11 12 3
Policy process 50 6 17 4 33 4 6 1
Programme evaluation 2 10 22 24 2 2 17 17 5 4 12 19 2 3 2 2 2 2 32 30 41 10
Quality 7 2 20 7 47 15 7 3 13 4 7 2 15 4
Research to evidence 33 2 33 2 33 2 3 1
Sector Analysis 11 11 11 10 8 8 11 8 8 7 3 11 47 40 36 9
None 26 14 5 2 11 5 5 3 47 20 5 11 0 19 5
n 10 37 54 41 48 26 40 50 46 9 43 404 100
% 2 100 9 100 13 100 10 100 12 100 6 100 10 100 12 100 11 100 2 100 11 100
A = % across the row ; B = % down the columnPage 10 of 12
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health systems and, equity and policy process, topics that
are more highly ranked in upper middle income
countries.
Comparing the research portfolio and the agendas
The overall ranking of topics in the reference list was com-
pared against the ranking of topics in projects initiated by
each actor. The relationship between actor preferences
and the reference list was assessed through an analysis of
their rank congruence.
As described in a previous paper in more detail [1], the
research institution is the initiator in 34% of projects,
while 31% are initiated by a donor agency, international
research partner or by a private contractor. Governments
initiate in 24% of cases. 12% of projects are reported as a
mix of the above and are not considered for this analysis.
The agendas across actors differ substantially, and none
can be said to be close to the other. As a result, the refer-
ence list shows marked difference with respect to each
actor's agenda. Government initiation shows preference
for financing and cost-effectiveness as compared to the
overall ranking. Government initiation tends to give
lower regard to disease burden studies and for research on
accessibility. International donor initiation matches best
the reference list but gives somewhat less preference to
sector-wide analyses. Research institution initiation is
more marked for equity and community participation
and less so for management and organization, accessibil-
ity and program evaluation. International donor initia-
tion preferences are associated to the top ranking topics in
the overall listing, suggesting a predominance of their
agenda on the reference list.
Conclusions
The analysis of the research portfolio and priorities at the
international level shows a widely diversified set of topics,
ranging from sector wide issues to more focused program
evaluation. The emphasis on sector wide issues reflects the
challenges to health systems today and suggests that coun-
tries consider as important the macro-level analysis as the
micro. Micro approaches with a focused attention to ben-
eficiaries or specific issues are well identified, particularly
under the topic of program evaluation.
However, the evidence also suggests a gap between the
research that is actually being undertaken and the chal-
lenges for strengthening and scaling up of disease control
programs. Such a gap is evident in the low emphasis given
to research on human resources, policy process, equity,
economic policy and health and information systems.
By contrast, the analysis suggests a high degree of atten-
tion at the community level, although much attention is
Table 5: Ranking of Topics in the Reference List and Differences by Income Region and by Project Initiation





Donors Govnt. Research 
Institution
1 Sector Analysis -- -
2 Disease burden --
3 Management & organization + --
4 Accessibility + + -- --
Programme evaluation --
Research to evidence - - +
5 Financing - ++ ++ --
Human resources +
6 Community participation - + + ++
Costing & cost effectiveness -- + + +++
Decentralisation/local health systems - +++ +
Information, Education and Communication +
Insurance -- +++ - +
Pharmaceutical policy & management
Quality +
7 Equity - +++ + +++
Policy process - +++
8 Economic policy and health - + + +
Information systems + +
Cells with a rank difference of 1, 0 or -1 are blank. Changes of 4 or more = +++; 3 = ++; 2 = +; -2 = -; -3 = --; -4 or more = ---Page 11 of 12
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also given at the hospital level. Primary care thus seems to
be under-emphasized. Considering the disease focus,
whenever this was made evident, the data do not suggest
a bias towards problems that would not be evidently
important at country level.
The fact that the public or private character of research
institutions is insignificant for the agenda suggests the
capacity of diverse institutions to work within a common
agenda.
There are significant differences in the research portfolio
across groups of countries based on per capita income,
suggesting the need for priority setting mechanisms at
both national and international levels that reflect such
diversity. The greater congruence between donor prefer-
ences and the international research agenda highlight the
importance of consensus building between national and
international actors. While it is appropriate for govern-
ments and international donors to fund different aspects
of the research portfolio, this requires high-level priority
setting and consensus mechanisms to ensure they com-
plement each other rather than lead to fragmentation.
More research is required to establish the relationships
between actors' agendas and the research portfolio at the
international level. There is also a need to discuss the most
desirable balance of influences and to increase the voice of
developing country actors. Evidence-based HPSR priori-
ties emerging through such a process would then be able
to support scaling up of research efforts on a par with scal-
ing up of health system strengthening and disease control.
Regional and global meetings, such as the Ministerial
Summit for Health Research to be held in Mexico in
November 2004, are good opportunities to present and
discuss the evidence and to commit funding accordingly.
Attention must be given to encouraging consensus build-
ing on research priorities within regions comprising coun-
tries with similar needs. The interests of donors,
governments, health workers, the community and
researchers must all be taken into consideration so that
research funding leads not only to fund relevant research




1. Gonzalez-Block MA, Mills A: Assessing capacity for health policy
and systems research in low and middle income countries.
Health Research Policy and Systems 2003, 1:1.
2. Ad hoc committee on health research concerning future
intervention options, Investing in health research and
development. Geneva, WHO 1996.
3. Harrison D: Health research: an essential tool for achieving
development through equity. In Forging links for health researchPer-
spectives from the Council on Health Research for Development Edited by:
Neufeld V, Johnson N. Ottawa, IDRC; 2001. 
4. Stokes D, Pasteur's quadrant: Basic science and technological
innovation. Washington DC, The Brookings Institution 1997.
5. Alliance for Health Policy and Systems Research, Develop-
ment of an HPSR Thesaurus. Newsletter of the Alliance-HPSR,
Geneva, No. 4 2001.
6. Gonzalez-Block MA: Comparative research and analysis meth-
ods for shared learning from health system reforms. Health
Policy 1997, 42:187-209.
7. Pang T, Sadana R, Health research systems: A framework for the
future. Bulletin of the World Health Organization 2003, 81:159.
8. Commission on Health Research for Development, Health research:
essential link to equity in development. Oxford, Oxford University
Press 1990.
9. Global Forum for Health Research: The 10/90 report on health
research 2001–2002. Geneva, GFHR 2003.Page 12 of 12
(page number not for citation purposes)
